UK Cancer Genetics Group Publishes New Position Statement on Recontact and Follow-up

Vicki, our CEO & Founder, is delighted to see the UK Cancer Genetics Group’s new position statement published following the recent consensus meeting, which she was privileged to contribute to.

This publication represents an important collaborative effort to establish consensus on recontact and follow-up for individuals with germline pathogenic variants in hereditary breast and ovarian cancer susceptibility genes. As genomic knowledge continues to evolve, clear guidance on recontact and long-term follow-up is essential to delivering high-quality, patient-centred care.

Congratulations to everyone involved in developing this important consensus statement.

Reference

Christopher J, Edgerley K, McIldowie B, Consensus Meeting Attendees, et al. Recontact and follow-up for individuals with germline pathogenic variants in hereditary breast and ovarian cancer susceptibility genes: a UK Cancer Genetics Group consensus meeting. Journal of Medical Genetics. 2026;63:57–63. https://jmg.bmj.com/content/63/1/57